Clinical trial
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
NCT00686842
Study timeline
Study start (unknown)2008-09-01Date precision: month
Registry last updated2018-06-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Kaposi's Sarcomaunresolved
Interventions
gene expression analysisGENETIC
polymerase chain reactionGENETIC
protein expression analysisGENETIC
biopsyPROCEDURE
Sponsors & collaborators
AIDS Malignancy Consortiumlead sponsor
National Cancer Institute (NCI)collaborator
PTC Therapeuticscollaborator
The Emmes Company, LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00686842 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.